Cargando…

Associations between urate-lowering therapy and the risk of type 2 diabetes mellitus

BACKGROUND: Gout is independently associated with increased risk of type 2 diabetes mellitus (T2DM). Urate-lowering therapy (ULT) might be beneficial in lowering the risks of T2DM. Therefore, we conducted a nested case-control study to evaluate the associations between ULT and T2DM. METHODS: This st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Hsin-Wen, Lin, Ya-Wen, Lin, Ming-Hung, Lan, Yu-Ching, Wang, Ruey-Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322774/ https://www.ncbi.nlm.nih.gov/pubmed/30615649 http://dx.doi.org/10.1371/journal.pone.0210085

Ejemplares similares

Association between Gout, Urate-Lowering Therapy, and Risk of Developing Type 2 Diabetes Mellitus: A Nationwide Population-Based Retrospective Cohort Study
por: Fang, Yi-Jen, et al.
Publicado: (2020)

Variation in serum urate levels in the absence of gout and urate lowering therapy
por: Shaffer, Andrew, et al.
Publicado: (2021)

Urate-Lowering Therapy Ameliorates Kidney Function in Type 2 Diabetes Patients With Hyperuricemia
por: Ueno, Naohiko
Publicado: (2017)

The association between hyperlipidemia, lipid-lowering drugs and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus
por: Chang, Kuo-Cheng, et al.
Publicado: (2023)

Adherence with urate-lowering therapies for the treatment of gout
por: Harrold, Leslie R, et al.
Publicado: (2009)

Urate‐lowering therapy for patients with gout on hemodialysis
por: Alkilany, Reem, et al.
Publicado: (2022)

Factors associated with initiation and persistence of urate-lowering therapy
por: Dehlin, Mats, et al.
Publicado: (2017)

Effect of Urate-Lowering Therapy on All-Cause and Cardiovascular Mortality in Hyperuricemic Patients without Gout: A Case-Matched Cohort Study
por: Chen, Jiunn-Horng, et al.
Publicado: (2015)

Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout
por: Yen, Fu-Shun, et al.
Publicado: (2021)

Impact of urate-lowering drugs on the progression and recovery from chronic kidney disease among gout patients
por: Chung, Ting-Ting, et al.
Publicado: (2019)

The impact of adoption of a new urate-lowering agent on trends in utilization and cost in practice
por: Peng, Yueh-Lung, et al.
Publicado: (2019)

Urate-lowering therapy may mitigate the risks of hospitalized stroke and mortality in patients with gout
por: Yen, Fu-Shun, et al.
Publicado: (2020)

Urate-Lowering Therapy May Prevent the Development of Coronary Artery Disease in Patients With Gout
por: Yen, Fu-Shun, et al.
Publicado: (2020)

Atrial Fibrillation Risk and Urate-Lowering Therapy in Patients with Gout: A Cohort Study Using a Clinical Database
por: Liu, Ching-Han, et al.
Publicado: (2022)

Treatment approaches and adherence to urate-lowering therapy for patients with gout
por: Aung, Thanda, et al.
Publicado: (2017)

Association of Herpes Zoster and Type 1 Diabetes Mellitus
por: Chen, Hsin-Hung, et al.
Publicado: (2016)

Association between urate-lowering therapies and cognitive decline in community-dwelling older adults
por: Molet-Benhamou, Luc, et al.
Publicado: (2022)

Physiology of Hyperuricemia and Urate-Lowering Treatments
por: Benn, Caroline L., et al.
Publicado: (2018)

Population-based study on birth outcomes among women with hypertensive disorders of pregnancy and gestational diabetes mellitus
por: Lin, Ya-Wen, et al.
Publicado: (2021)

Glycemic control and adherence to basal insulin therapy in Taiwanese patients with type 2 diabetes mellitus
por: Chien, Ming‐Nan, et al.
Publicado: (2016)

Acute kidney injury caused by ammonium acid urate crystals in diabetic ketoacidosis at the onset of type 1 diabetes mellitus
por: Shimazaki, Shunsuke, et al.
Publicado: (2021)

Inverse associations between serum urate and glycemic status in a general population and in persons with diabetes mellitus
por: Wakabayashi, Ichiro
Publicado: (2020)

The Effect of Decrease in Serum Urate for the Risk of Gout Flares During Urate-Lowering Therapy Initiation Among Chinese Male Gout Patients: A Prospective Cohort Study
por: Pang, Lei, et al.
Publicado: (2023)

Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout
por: Dalbeth, Nicola, et al.
Publicado: (2012)

Impact of diuretics on the urate lowering therapy in patients with gout: analysis of an inception cohort
por: Ranieri, Laura, et al.
Publicado: (2018)

Depressive Symptoms and the Effectiveness of a Urate‐Lowering Therapy in a Clinical Trial
por: Mrug, Sylvie, et al.
Publicado: (2020)

Persistence with urate‐lowering therapy in Australia: A longitudinal analysis of allopurinol prescriptions
por: Coleshill, Matthew J., et al.
Publicado: (2022)

Gout Remission as a Goal of Urate-Lowering Therapy: A Critical Review
por: Tabi-Amponsah, Adwoa Dansoa, et al.
Publicado: (2023)

Acute large-dose exposure to organophosphates in patients with and without diabetes mellitus: analysis of mortality rate and new-onset diabetes mellitus
por: Liu, Shou-Hsuan, et al.
Publicado: (2014)

Rate of adherence to urate-lowering therapy among patients with gout: a systematic review and meta-analysis
por: Yin, Rulan, et al.
Publicado: (2018)

Association between clinical use of lansoprazole and the risk of type 2 diabetes mellitus: a pharmacoepidemiological cohort study
por: Lin, Ming-Hsun, et al.
Publicado: (2023)

Review of Urate-Lowering Therapeutics: From the Past to the Future
por: Jenkins, Christopher, et al.
Publicado: (2022)

Herbal Therapies for Type 2 Diabetes Mellitus: Chemistry, Biology, and Potential Application of Selected Plants and Compounds
por: Chang, Cicero L. T., et al.
Publicado: (2013)

Interventions to improve uptake of urate-lowering therapy in patients with gout: a systematic review
por: Gill, Iqbal, et al.
Publicado: (2020)

Development of a patient decision aid for the initiation of urate-lowering therapy in gout patients
por: te Kampe, Ritch, et al.
Publicado: (2022)

Hyperuricemia, urate-lowering therapy, and kidney outcomes: a systematic review and meta-analysis
por: Sharma, Gaurav, et al.
Publicado: (2021)

Beliefs of rheumatologists and general practitioners on urate lowering therapy: a cross-sectional study
por: Veenstra, Frouwke, et al.
Publicado: (2023)

Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies
por: Chang, Shang-Hung, et al.
Publicado: (2014)

The Impact of Urate‐Lowering Therapy in Post‐Myocardial Infarction Patients: Insights From a Population‐Based, Propensity Score‐Matched Analysis
por: Tai, Chi‐Jung, et al.
Publicado: (2021)

Evaluating the urate-lowering effects of different microbial fermented extracts in hyperuricemic models accompanied with a safety study
por: Chen, Rong-Jane, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9t8tqpivueev544alsdusmd7qi